Trial intelligence / Profile preview

Postoperative opioid requirement: intravenous nalbuphine vs morphine after cesarean section under spinal anesthesia

TCTR20210903005Phase 4Completed

Sponsor
N/A
Start
Jan 2022
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nalbuphine, morphine in postoperative pain, sponsored by N/A. Started Jan 2022; status: completed.

02

Drugs

nalbuphinemorphine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on TCTR20210903005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210903005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call